Antithrombotic Drug with Low Risk of Bleeding
Anti-fibrotic Drug Targeting ECM
Modification Platforms for Protein Therapeutics
Fibrin and Platelet-targeting Thrombolytic Drug
Bispecific Drugs for Cancers
Protein Production and GLP Laboratory